A Phase 1, Active and Placebo-Controlled, Multiple-Dose Escalation Trial Evaluating the Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of PF-04171327 (Part 1), and a Single Dose Pharmacokinetic Assessment of a Tablet Formulation (Part 2) in Healthy Volunteers.
Phase of Trial: Phase I
Latest Information Update: 16 Jun 2010
At a glance
- Drugs Fosdagrocorat (Primary) ; Prednisolone
- Indications Rheumatoid arthritis
- Focus Adverse reactions; Biomarker; Pharmacodynamics; Pharmacokinetics
- Sponsors Pfizer
- 16 Jun 2010 Results have been presented at the 11th Annual Congress of the European League Against Rheumatism.
- 13 Aug 2009 Actual patient number (21) added as reported by ClinicalTrials.gov.
- 13 Aug 2009 Status changed from recruiting to completed as reported by ClinicalTrials.gov.